AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure

RecruitingNAAges 18 Years - anyAllOslo University Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Acute hypoxemic respiratory failure may progress to acute respiratory distress syndrome, a life-threatening condition that often requires mechanical ventilation. The optimal ventilation strategy in this patient population remains uncertain. The SVALBARD trial is a feasibility and pilot study designed to compare spontaneous versus controlled mechanical ventilation in patients with acute hypoxemia respiratory failure. The primary objective is to assess the feasibility of the study procedures and interventions, while also collecting descriptive data on key clinical variables to inform the design of a future randomized controlled trial.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: We will include patients who fulfil all the following criteria: * Acutely admitted to the ICU * AND age โ‰ฅ 18 years * AND invasive mechanical ventilation via endotracheal tube or tracheostomy for less than 24 hours * AND moderate acute hypoxemic respiratory failure, defined as a PaOโ‚‚-FiOโ‚‚ ratio between 13.3-26.6 kPa (100-200 mmHg) with PEEP โ‰ฅ 5 cm H2O, based on arterial blood gas analysis obtained within 2 hours before randomisation. * AND new pulmonary infiltrate (uni- or bilateral) on chest x-ray or CT-scan obtained no more than 24 hours before randomisation. Exclusion Criteria: * Previously randomised into the SVALBARD trial. * Informed consent following inclusion expected to be unobtainable * Patient under coercive measures * Withdrawal from active therapy or brain death deemed imminent. * Chronic hypercapnic respiratory failure defined as PaCO2 \> 8 kPa (60 mm Hg) in the outpatient setting. * Listed for lung transplant. * Acute heart failure / acute myocardial infarction / cardiac arrest during or causing index ICU admission. * Use of home oxygen. * Chronic mechanical ventilation for any reason except for non-invasive mechanical ventilation (CPAP/BIPAP) used solely for sleep apnoea disorder. * Currently receiving ECMO therapy. * Burns \>70 % total body surface. * Acute brain injury or stroke (any, including subarachnoid haemorrhage, SAH). * Intracranial hypertension. * Patients with planned repeat surgical interventions during current stay in ICU.
๐Ÿ’Š

What it tests

  • Spontaneous Ventilation Strategy
  • Controlled Ventilation Strategy
๐Ÿ“

Where

1 site
Oslo University Hospital - Rikshospitalet
Oslo, Norway
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy